News

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.

More than 10 years after his diagnosis, he’s helping other people with the same rare cancer to hold on to hope.

Survival rates for Black women are far worse after bystander CPR than for white men, according to a study published this month.

USA Today talked to Dr. Paul Chan about disparities found when analyzing the effectiveness of bystander CPR for cardiac arrest.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

We’re talking about how younger women and men can monitor for breast cancer and recent updates in screening guidelines.

This week during Breast Cancer Awareness Month, we’re talking about metastatic breast cancer and Saint Luke’s Koontz Center—the region’s only center dedicated and designed specifically for these patients.